BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16705817)

  • 1. How much should we involve genetic and environmental factors in the risk assessment of mycotoxins in humans?
    Creppy EE; Moukha S; Bacha H; Carratu MR
    Int J Environ Res Public Health; 2005 Apr; 2(1):186-93. PubMed ID: 16705817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ochratoxin A in human blood in relation to nephropathy in Tunisia.
    Maaroufi K; Achour A; Hammami M; el May M; Betbeder AM; Ellouz F; Creppy EE; Bacha H
    Hum Exp Toxicol; 1995 Jul; 14(7):609-14. PubMed ID: 7576823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ochratoxin A and human chronic nephropathy in Tunisia: is the situation endemic?
    Abid S; Hassen W; Achour A; Skhiri H; Maaroufi K; Ellouz F; Creppy E; Bacha H
    Hum Exp Toxicol; 2003 Feb; 22(2):77-84. PubMed ID: 12693831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Karyomegaly of tubular kidney cells in human chronic interstitial nephropathy in Tunisia: respective role of Ochratoxin A and possible genetic predisposition.
    Hassen W; Abid-Essafi S; Achour A; Guezzah N; Zakhama A; Ellouz F; Creppy EE; Bacha H
    Hum Exp Toxicol; 2004 Jul; 23(7):339-46. PubMed ID: 15311851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ochratoxin A and beta2-microglobulinuria in healthy individuals and in chronic interstitial nephropathy patients in the centre of Tunisia: a hot spot of Ochratoxin A exposure.
    Hassen W; Abid S; Achour A; Creppy E; Bacha H
    Toxicology; 2004 Jul; 199(2-3):185-93. PubMed ID: 15147792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Karyomegaly of tubular cells as early stage marker of the nephrotoxicity induced by ochratoxin A in rats.
    Maaroufi K; Zakhama A; Baudrimont I; Achour A; Abid S; Ellouz F; Dhouib S; Creppy EE; Bacha H
    Hum Exp Toxicol; 1999 Jun; 18(6):410-5. PubMed ID: 10413246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ochratoxin A and β2-microglobulin in BEN patients and controls.
    Yordanova P; Wilfried K; Tsolova S; Dimitrov P
    Toxins (Basel); 2010 Apr; 2(4):780-92. PubMed ID: 22069610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary cholestyramine reduces ochratoxin A-induced nephrotoxicity in the rat by decreasing plasma levels and enhancing fecal excretion of the toxin.
    Kerkadi A; Barriault C; Tuchweber B; Frohlich AA; Marquardt RR; Bouchard G; Yousef IM
    J Toxicol Environ Health A; 1998 Feb; 53(3):231-50. PubMed ID: 9482354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New data on the occurrence of ochratoxin A in human sera from patients affected or not by renal diseases in Tunisia.
    Grosso F; Saíd S; Mabrouk I; Fremy JM; Castegnaro M; Jemmali M; Dragacci S
    Food Chem Toxicol; 2003 Aug; 41(8):1133-40. PubMed ID: 12842181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ochratoxin A levels in human serum and foods from nephropathy patients in Tunisia: where are you now?
    Hmaissia Khlifa K; Ghali R; Mazigh C; Aouni Z; Machgoul S; Hedhili A
    Exp Toxicol Pathol; 2012 Jul; 64(5):509-12. PubMed ID: 21146381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The involvement of mycotoxins in the development of endemic nephropathy.
    Peraica M; Domijan AM; Miletić-Medved M; Fuchs R
    Wien Klin Wochenschr; 2008; 120(13-14):402-7. PubMed ID: 18726664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foodstuffs and human blood contamination by the mycotoxin ochratoxin A: correlation with chronic interstitial nephropathy in Tunisia.
    Maaroufi K; Achour A; Betbeder AM; Hammami M; Ellouz F; Creppy EE; Bacha H
    Arch Toxicol; 1995; 69(8):552-8. PubMed ID: 8534199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of ochratoxin A in Tunisian blood nephropathy patients. Exposure level to OTA.
    Zaied C; Bouaziz C; Azizi I; Bensassi F; Chour A; Bacha H; Abid S
    Exp Toxicol Pathol; 2011 Nov; 63(7-8):613-8. PubMed ID: 20708395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effects of fumonisin B1 and ochratoxin A: are in vitro cytotoxicity data predictive of in vivo acute toxicity?
    Creppy EE; Chiarappa P; Baudrimont I; Borracci P; Moukha S; Carratù MR
    Toxicology; 2004 Sep; 201(1-3):115-23. PubMed ID: 15297026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary biomarkers of ochratoxin A and citrinin exposure in two Bangladeshi cohorts: follow-up study on regional and seasonal influences.
    Ali N; Blaszkewicz M; Alim A; Hossain K; Degen GH
    Arch Toxicol; 2016 Nov; 90(11):2683-2697. PubMed ID: 26705708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ochratoxins in Wines: A Review of Their Occurrence in the Last Decade, Toxicity, and Exposure Risk in Humans.
    Ortiz-Villeda B; Lobos O; Aguilar-Zuniga K; Carrasco-Sánchez V
    Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ochratoxin A in human kidney diseases.
    Fuchs R; Peraica M
    Food Addit Contam; 2005; 22 Suppl 1():53-7. PubMed ID: 16332622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ochratoxin A contamination of food from Croatia.
    Peraica M; Flajs D; Domijan AM; Ivić D; Cvjetković B
    Toxins (Basel); 2010 Aug; 2(8):2098-105. PubMed ID: 22069674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How aspartame prevents the toxicity of ochratoxin A.
    Creppy EE; Baudrimont I; Anne-Marie
    J Toxicol Sci; 1998 Jul; 23 Suppl 2():165-72. PubMed ID: 9760456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental mycotoxic nephropathy in pigs provoked by a diet containing ochratoxin A and penicillic acid.
    Stoev SD; Vitanov S; Anguelov G; Petkova-Bocharova T; Creppy EE
    Vet Res Commun; 2001 Apr; 25(3):205-23. PubMed ID: 11334150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.